IDH2 and central nervous system cancer: In addition, IDH-mutant gliomas with deletions of chromosome arms 1p and 19q (1p/19q-codeleted), characterize the oligodendroglioma subtype with more favorable overall survival in comparison to IDH-mutant gliomas with retained 1p/19q (astrocytomas).